Martin Vazquez Biography and Net Worth

COO of Outset Medical

Martín Vazquez joined Outset as Chief Operating Officer in October 2017. He has nearly three decades of progressive, cross-functional leadership experience in operations, product development, and quality assurance of class I-III medical devices. Prior to Outset, Martín was Vice President of North America Operations and Global S&OP at Abbott Rapid Dx (formerly Alere). He has solid track record in operations strategy planning and execution, quality and product engineering at a variety of companies with highly regulated supply networks including Becton Dickinson, Carefusion, Smiths Medical, Greatbatch, Alcon, and Ethicon (J&J).

Martín received his undergraduate degree from The University of Texas and his MBA from the Marshall School of Business, USC.

What is Martin Vazquez's net worth?: The estimated net worth of Martin Vazquez is at least $75,957.70 as of March 1st, 2023. Mr. Vazquez owns 6,874 shares of Outset Medical stock worth more than $75,958 as of March 26th. This net worth approximation does not reflect any other investments that Mr. Vazquez may own. Learn More about Martin Vazquez's net worth.
How do I contact Martin Vazquez?: The corporate mailing address for Mr. Vazquez and other Outset Medical executives is 3052 ORCHARD DRIVE, SAN JOSE CA, 95134. Outset Medical can also be reached via phone at 669-231-8200 and via email at investors@outsetmedical.com. Learn More on Martin Vazquez's contact information.
Has Martin Vazquez been buying or selling shares of Outset Medical?: Martin Vazquez has not been actively trading shares of Outset Medical in the last ninety days. Most recently, Martin Vazquez sold 333 shares of the business's stock in a transaction on Wednesday, March 1st. The shares were sold at an average price of $334.95, for a transaction totalling $111,538.35. Following the completion of the sale, the chief operating officer now directly owns 6,874 shares of the company's stock, valued at $2,302,446.30. Learn More on Martin Vazquez's trading history.
Who are Outset Medical's active insiders?: Outset Medical's insider roster includes Nabeel Ahmed (VP), John Brottem (General Counsel), Rebecca Chambers (CFO), D. Grossman (Director), James Hinrichs (Director), Leslie Trigg (CEO), Martin Vazquez (COO), and Steven Williamson (Insider). Learn More on Outset Medical's active insiders.
Are insiders buying or selling shares of Outset Medical?: In the last year, insiders at the sold shares 30 times. They sold a total of 25,398 shares worth more than $488,275.65. The most recent insider tranaction occured on February, 18th when CEO Leslie Trigg sold 974 shares worth more than $13,149.00. Insiders at Outset Medical own 4.1% of the company. Learn More about insider trades at Outset Medical.
Information on this page was last updated on 2/18/2025.

Martin Vazquez Insider Trading History at Outset Medical

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/1/2023	Sell	333	$334.95	$111,538.35	6,874
2/16/2023	Sell	128	$365.40	$46,771.20	6,833
2/2/2023	Sell	1,300	$450.00	$585,000.00	6,962
1/27/2023	Sell	311	$418.80	$130,246.80	6,962
1/3/2023	Sell	333	$392.10	$130,569.30	3,286
12/1/2022	Sell	333	$312.75	$104,145.75	3,286
11/11/2022	Sell	1,000	$300.00	$300,000.00	3,303
8/16/2022	Sell	17	$322.20	$5,477.40	3,265
8/1/2022	Sell	666	$300.00	$199,800.00	3,282
6/1/2022	Sell	333	$321.30	$106,992.90	3,282
5/17/2022	Sell	17	$395.40	$6,721.80	3,282
5/2/2022	Sell	333	$533.70	$177,722.10	3,299
4/1/2022	Sell	1,333	$686.55	$915,171.15	3,299
3/16/2022	Sell	68	$596.55	$40,565.40
3/1/2022	Sell	333	$652.65	$217,332.45
1/3/2022	Sell	1,066	$705.75	$752,329.50
11/1/2021	Sell	766	$840.90	$644,129.40
10/1/2021	Sell	1,066	$730.65	$778,872.90
9/17/2021	Sell	433	$825.00	$357,225.00	1,050
9/1/2021	Sell	333	$737.55	$245,604.15
5/3/2021	Sell	333	$871.20	$290,109.60	812
4/1/2021	Sell	1,500	$825.75	$1,238,625.00	1,464

See Full Table

Martin Vazquez Buying and Selling Activity at Outset Medical

Outset Medical Company Overview

Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company offers Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables. It also provides Tablo Data Ecosystem, including TabloHub, a customer-facing portal; MyTablo, a patient-facing portal; and TabloDash, an internal data analytics platform. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.

Today's Range

Now: $11.25

$10.64

$12.13

50 Day Range

MA: $11.33

$8.25

$14.40

2 Week Range

Now: $11.25

$5.85

$78.30

Volume

183,349 shs

Average Volume

89,980 shs

Market Capitalization

$40.44 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.01